Clin2
NCT06782217Possibly a fitRecruiting

Safety study of bee and wasp venom allergy shots

Allergy, Insect VenomAllergy Insect StingingInsect Sting Allergy

Part of Immune system & allergy clinical trials.

This study monitors the safety of venom immunotherapy (allergy shots) for people with bee or wasp sting allergies. If you are starting this treatment, researchers will track how well you tolerate it over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
14 years and older
Study type
Observational

Who can take part

  • You are 14 years or older.
  • You have been diagnosed with an allergy to bee or wasp venom, and your doctor plans to start you on venom immunotherapy.
  • You have not received venom immunotherapy (allergy shots for bee/wasp stings) in the last 5 years.
  • You are not pregnant or breastfeeding.
  • You do not have active cancer, an autoimmune disease, or any condition that makes allergy shots unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06790368Recruiting
Venom allergy treatment in real-life settings

This trial tests a venom immunotherapy for people allergic to bee or wasp stings. It aims to see how well the treatment works in everyday medical practice.

Alcorcón, Madrid
NCT04435990Recruiting· Phase 3
Allergy shots for dust mites in teens and adults

This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.

Santiago de Compostela, A Coruña
NCT07309822Recruiting
Beltaven® venom allergy immunotherapy study

This study tests a treatment called Beltaven® for people with severe allergic reactions to bee, wasp, or hornet stings. It aims to see if the treatment is safe and helps prevent future reactions.

Barcelona, Barcelona
NCT04259359Recruiting
Bee sting allergy trial for people starting venom immunotherapy

This trial studies whether having strong reactions to a specific bee venom protein can make venom immunotherapy less effective. It may help doctors better predict who is at higher risk for therapy failure after bee stings.

Graz
NCT07721233Not yet recruiting
Can virtual reality change immune responses in people with allergies?

This study tests if virtual reality experiences can affect the immune system in people with bee or wasp venom allergies. It may help understand new ways to treat allergies.

NCT06156046Recruiting
Understanding bee venom tolerance in beekeepers

This study looks at how beekeepers develop tolerance to bee venom over time, comparing people who are new to beekeeping, experienced beekeepers without allergies, and beekeepers who have had a recent allergic reaction. If you fall into one of these groups, you may be able to join and help researchers understand how the immune system adapts to bee stings.

Plymouth, Devon

Hear when a new Allergy, Insect Venom trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.